Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34378
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tseitkin, Boris | - |
dc.contributor.author | Mårtensson, Johan | - |
dc.contributor.author | Eastwood, Glenn M | - |
dc.contributor.author | Brown, Alastair | - |
dc.contributor.author | Ancona, Paolo | - |
dc.contributor.author | Lucchetta, Luca | - |
dc.contributor.author | Iwashyna, Theodore J | - |
dc.contributor.author | Robbins, Raymond J | - |
dc.contributor.author | Bellomo, Rinaldo | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-12-13T05:24:34Z | - |
dc.date.available | 2023-12-13T05:24:34Z | - |
dc.date.issued | 2020-12 | - |
dc.identifier.citation | Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine 2020-12; 22(4) | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/34378 | - |
dc.description.abstract | Background: Persistent critical illness (PerCI) is defined as an intensive care unit (ICU) admission lasting ≥ 10 days. The in-hospital complications associated with its development are poorly understood. Aims: To test whether PerCI is associated with a greater prevalence, rate and specific types of in-hospital complications. Methods: Single-centre, retrospective, observational case-control study. Results: We studied 1200 patients admitted to a tertiary ICU from 2010 to 2015. Median ICU length of stay was 16 days (interquartile range [IQR], 12-23) for PerCI patients v 2.3 days (IQR, 1.1-3.7) for controls, and median hospital length of stay was 41 days (IQR, 22-75) v 8 days (IQR, 4-17) respectively. A greater proportion of PerCI patients received acute renal replacement therapy (37% v 6.8%) or underwent reintubation (17% v 1%) and/or tracheostomy (36% v 0.6%); P < 0.0001. Despite these complications, PerCI patients had similar hospital mortality (29% v 27%; P = 0.53). PerCI patients experienced a greater absolute number of complications (12.1 v 4.0 complications per patient; P < 0.0001) but had fewer exposure-adjusted complications (202 v 272 complications per 1000 hospital bed-days; P < 0.001) and a particularly high overall prevalence of specific complications. Conclusions: PerCI patients experience a higher prevalence, but not a higher rate, of exposure-adjusted complications. Some of these complications appear amenable to prevention, helping to define intervention targets in patients at risk of PerCI. Funding: Austin Hospital Intensive Care Trust Fund. | en_US |
dc.language.iso | eng | - |
dc.title | Nature and impact of in-hospital complications associated with persistent critical illness. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine | en_US |
dc.identifier.affiliation | Intensive Care | en_US |
dc.identifier.affiliation | Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. | en_US |
dc.identifier.affiliation | Australian and New Zealand Intensive Care Society Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Department of Intensive Care Medicine, Catholic University of the Sacred Heart, "A. Gemelli" University Hospital, Rome, Italy. | en_US |
dc.identifier.affiliation | Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. | en_US |
dc.identifier.affiliation | Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.;Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA. | en_US |
dc.identifier.affiliation | Administrative Informatics, Austin Hospital, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | Australian and New Zealand Intensive Care Society Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.;School of Medicine, University of Melbourne, Melbourne, VIC, Australia.;Data Analytics Research and Evaluation (DARE) Centre, Austin Hospital and University of Melbourne, Melbourne, VIC, Australia.;Department of Intensive Care, Royal Melbourne Hospital, VIC, Australia. | en_US |
dc.identifier.doi | 10.51893/2020.4.OA11 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 38046870 | - |
dc.description.volume | 22 | - |
dc.description.issue | 4 | - |
dc.description.startpage | 378 | - |
dc.description.endpage | 387 | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Clinical Analytics and Reporting | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.